Without a matched peripheral blood sample, TILs possessing CHIP‐related mutations detected within a tumor sample could lead to erroneous calling of tissue‐specific tumor variants [89], potentially leading to recommendations for inappropriate targeted therapies. Here, STUB1 is linked to neoplasm.